重新构想MDR病原体的菌体疗法:从生物银行到卫生系统整合 - - 一篇评论
Abay A Ayele1,2, Wenfeng Liu3, Minfeng Xiao3
1Genomics and Bioinformatics Division, Armauer Hansen Research Institute, Addis Ababa, Ethiopia. abay.gsr-3629-17@aau.edu.et.
Infectious diseases and therapy
|March 7, 2026
概括
多种耐药性病原体威胁低收入国家. 本次审查提出了一份5P路线图,以实施菌体 (菌体) 治疗,解决生物库,制剂,临床前验证,政策和针对抗菌素耐药性策略的试点试验.
科学领域:
- 微生物学与传染病的研究
- 生物技术和制药科学 生物技术和制药科学
- 全球卫生和卫生系统
背景情况:
- 多药耐药 (MDR) 病原体,如Klebsiella pneumoniae,构成了全球严重的健康威胁,特别是在低收入和中等收入国家 (LMICs),治疗选择有限.
- 菌体 (菌体) 治疗为抗生素提供了一种特定的,潜在的低成本替代品,在体外和个性化治疗中已证明有效.
- 显著的障碍阻碍了菌体治疗在LMICs的临床整合,包括缺乏本地菌体银行和不清楚的监管框架.
研究的目的:
- 提出针对资源有限的卫生系统量身定制的细菌治疗的结构化实施框架.
- 在LMIC中弥合实验室疗效和菌体疗法的临床应用之间的翻译差距.
- 为将菌体治疗纳入国家抗菌素耐药性战略提供可操作的蓝图.
主要方法:
- 综合当前关于菌体治疗疗效和实施挑战的证据.
- "5-P路线图"框架的制定:体宿主生物库,制剂,临床前验证 (包括体抗生素协同作用),政策和监管途径以及试点临床试验.
- 专注于适用于资源有限的环境和卫生系统整合的战略.
主要成果:
- 5P路线图为推进菌体疗法实施提供了一个统一的战略.
- 该框架解决了LMIC的主要系统性障碍,例如建立集成的菌体宿主生物库和开发适合环境的菌体制剂.
- 它强调严格的临床前验证,包括菌体-抗生素协同作用,以及政策和监管途径的并行发展.
结论:
- 拟议的5-P路线图为在LMICs中推进细菌治疗提供了一个可行的蓝图.
- 同时关注路线图的相互关联的支柱对于成功实施至关重要.
- 这一框架可以促进可扩展,公平和可持续的菌体疗法的整合,作为对抗低低收入国家中抗菌素耐药性的辅助.
相关概念视频
01:30Lytic Cycle of Bacteriophages
60.5K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
60.5K
01:29Microorganisms in Medicine and Therapeutics
1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
01:26DNA Bacteriophages
1.6K
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.6K
01:26Human Virome
54
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
54
01:25Clinical Significance of Antibiotic Resistance
106
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
106